The co-operation between Orla DTx Oy and Roche Diagnostics Oy takes patients to a new level of self-care in Finland. Orla INR Remote Monitoring, a service that includes the Roche Diagnostics CoaguChek® INRange measuring instrument, and the Orla Remote Measurement mobile application, enables patients a new level of self-care. When using the Roche Diagnostics CoaguChek® INRange measuring instrument as well as the Orla Remote Measurement mobile application, patients are able to perform INR measurement from the comfort of their own home, while still having direct contact to the health care professionals.
The Orla INR Remote Monitoring has recently received the Digi-HTA recommendation with a maximum score (10/10) in the assessment of the Finnish Coordination Centre for Health Technology Assessment (FinCCHTA). It is becoming an evermore established process to issue recommendations for digital health solutions available on the market. As the recommendation gives health care professionals and decision makers a reliable and impartial assessment of different digital health products, the procurement decisions of healthcare organizations can be simplified. The assessment looks into the effectiveness, safety, costs, security and data protection, as well as the usability and accessibility of the service.
Read more about the co-operation between Orla DTx Oy and Roche Diagnostics Oy, and the Digi-HTA recommendation here (the English text is found below the Finnish text).